Literature DB >> 3130877

Embryologic and other developmental considerations of thirty-eight possible variants of the DiGeorge anomaly.

R A Thomas1, B H Landing, T R Wells.   

Abstract

The DiGeorge anomaly (DGA) represents a polytopic developmental field defect that can be caused by a number of different chromosomal, mendelian, toxic, or metabolic factors operating in early embryonic life. If the affected field is thought to be focused on either the fourth branchial arch or the third branchial pouch, with variable cephalad or caudad extension, 38 different combinations of malformations can include DiGeorge anomalies, 24 complete and 14 partial DGA, with the constraints that the field defect must be contiguous (involvement of more than one branchial arch or pouch requires involvement of all intervening arches or pouches) and complete (all derivatives of an affected branchial arch or pouch are deficient). The types and relative frequencies of abnormalities of structures other than the thymus and parathyroid glands in these possible "subsets" of DGA are discussed, and the need for more data on their occurrence in patients diagnosed as having DGA is emphasized.

Entities:  

Mesh:

Year:  1987        PMID: 3130877     DOI: 10.1002/ajmg.1320280508

Source DB:  PubMed          Journal:  Am J Med Genet Suppl        ISSN: 1040-3787


  10 in total

1.  Mechanisms of tolerance to parental parathyroid tissue when combined with human allogeneic thymus transplantation.

Authors:  Ivan K Chinn; John A Olson; Michael A Skinner; Elizabeth A McCarthy; Stephanie E Gupton; Dong-Feng Chen; Francisco A Bonilla; Robert L Roberts; Maria G Kanariou; Blythe H Devlin; M Louise Markert
Journal:  J Allergy Clin Immunol       Date:  2010-09-15       Impact factor: 10.793

Review 2.  Autoimmunity in Primary Immunodeficiencies (PID).

Authors:  Grace T Padron; Vivian P Hernandez-Trujillo
Journal:  Clin Rev Allergy Immunol       Date:  2022-06-01       Impact factor: 8.667

3.  Longitudinal analysis of immune function in the first 3 years of life in thymectomized neonates during cardiac surgery.

Authors:  E Mancebo; J Clemente; J Sanchez; J Ruiz-Contreras; P De Pablos; S Cortezon; E Romo; E Paz-Artal; L M Allende
Journal:  Clin Exp Immunol       Date:  2008-09-22       Impact factor: 4.330

4.  Long-term tolerance to allogeneic thymus transplants in complete DiGeorge anomaly.

Authors:  Ivan K Chinn; Blythe H Devlin; Yi-Ju Li; M Louise Markert
Journal:  Clin Immunol       Date:  2007-12-26       Impact factor: 3.969

5.  Review of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation: outcome of 44 consecutive transplants.

Authors:  M Louise Markert; Blythe H Devlin; Marilyn J Alexieff; Jie Li; Elizabeth A McCarthy; Stephanie E Gupton; Ivan K Chinn; Laura P Hale; Thomas B Kepler; Min He; Marcella Sarzotti; Michael A Skinner; Henry E Rice; Jeffrey C Hoehner
Journal:  Blood       Date:  2007-02-06       Impact factor: 22.113

6.  Congenital heart disease in CHARGE association.

Authors:  R K Wyse; S al-Mahdawi; J Burn; K Blake
Journal:  Pediatr Cardiol       Date:  1993-03       Impact factor: 1.655

Review 7.  Human T cell reconstitution in DiGeorge syndrome and HIV-1 infection.

Authors:  Lori L Hudson; M Louise Markert; Blythe H Devlin; Barton F Haynes; Gregory D Sempowski
Journal:  Semin Immunol       Date:  2007-11-26       Impact factor: 11.130

Review 8.  Absent aortic and pulmonary valves: investigation of three fetal cases with cystic hygroma and review of the literature.

Authors:  S Miyabara; M Ando; K Yoshida; N Saito; H Sugihara
Journal:  Heart Vessels       Date:  1994       Impact factor: 2.037

9.  Factors affecting success of thymus transplantation for complete DiGeorge anomaly.

Authors:  M L Markert; B H Devlin; I K Chinn; E A McCarthy; Y J Li
Journal:  Am J Transplant       Date:  2008-06-28       Impact factor: 8.086

10.  The dynamics of T-cell receptor repertoire diversity following thymus transplantation for DiGeorge anomaly.

Authors:  Stanca M Ciupe; Blythe H Devlin; M Louise Markert; Thomas B Kepler
Journal:  PLoS Comput Biol       Date:  2009-06-12       Impact factor: 4.475

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.